A detailed history of Ubs Group Ag transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Ubs Group Ag holds 529,398 shares of ANIX stock, worth $1.42 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
529,398
Previous 530,540 0.22%
Holding current value
$1.42 Million
Previous $1.17 Million 42.24%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.21 - $3.48 $2,523 - $3,974
-1,142 Reduced 0.22%
529,398 $1.67 Million
Q2 2024

Aug 13, 2024

SELL
$2.21 - $3.35 $12,745 - $19,319
-5,767 Reduced 1.08%
530,540 $1.17 Million
Q1 2024

May 13, 2024

SELL
$3.08 - $5.02 $136,354 - $222,240
-44,271 Reduced 7.63%
536,307 $1.67 Million
Q4 2023

Feb 09, 2024

SELL
$2.85 - $4.19 $68,003 - $99,977
-23,861 Reduced 3.95%
580,578 $2.25 Million
Q3 2023

Nov 09, 2023

SELL
$2.97 - $3.87 $88,624 - $115,480
-29,840 Reduced 4.7%
604,439 $1.98 Million
Q2 2023

Aug 11, 2023

SELL
$3.0 - $5.97 $14,151 - $28,160
-4,717 Reduced 0.74%
634,279 $2.03 Million
Q1 2023

May 12, 2023

BUY
$3.86 - $5.0 $63,504 - $82,260
16,452 Added 2.64%
638,996 $2.75 Million
Q4 2022

Feb 08, 2023

BUY
$3.78 - $5.81 $3,224 - $4,955
853 Added 0.14%
622,544 $2.65 Million
Q3 2022

Nov 10, 2022

BUY
$2.81 - $6.15 $45,760 - $100,152
16,285 Added 2.69%
621,691 $3.06 Million
Q2 2022

Aug 10, 2022

BUY
$2.55 - $4.1 $17,760 - $28,556
6,965 Added 1.16%
605,406 $1.85 Million
Q1 2022

May 16, 2022

BUY
$2.5 - $3.42 $6,605 - $9,035
2,642 Added 0.44%
598,441 $1.64 Million
Q4 2021

Feb 14, 2022

BUY
$2.88 - $5.5 $38,566 - $73,650
13,391 Added 2.3%
595,799 $1.77 Million
Q3 2021

Nov 15, 2021

SELL
$3.57 - $5.6 $374,471 - $587,406
-104,894 Reduced 15.26%
582,408 $2.78 Million
Q2 2021

Aug 13, 2021

BUY
$3.46 - $4.92 $345,380 - $491,119
99,821 Added 16.99%
687,302 $2.67 Million
Q1 2021

May 12, 2021

SELL
$3.27 - $7.14 $100,591 - $219,640
-30,762 Reduced 4.98%
587,481 $2.75 Million
Q4 2020

Feb 11, 2021

BUY
$1.94 - $3.19 $174,988 - $287,738
90,200 Added 17.08%
618,243 $1.9 Million
Q3 2020

Nov 12, 2020

BUY
$1.79 - $3.3 $12,977 - $23,925
7,250 Added 1.39%
528,043 $1.28 Million
Q2 2020

Jul 31, 2020

BUY
$1.53 - $3.06 $274,096 - $548,192
179,148 Added 52.44%
520,793 $1.59 Million
Q1 2020

May 01, 2020

BUY
$1.35 - $4.06 $68,289 - $205,375
50,585 Added 17.38%
341,645 $543,000
Q4 2019

Feb 14, 2020

BUY
$2.78 - $4.03 $83,447 - $120,968
30,017 Added 11.5%
291,060 $955,000
Q3 2019

Nov 14, 2019

BUY
$3.53 - $4.7 $96,369 - $128,310
27,300 Added 11.68%
261,043 $1.04 Million
Q2 2019

Aug 14, 2019

BUY
$3.47 - $4.75 $93,690 - $128,250
27,000 Added 13.06%
233,743 $848,000
Q1 2019

May 14, 2019

BUY
$3.85 - $5.53 $147,840 - $212,352
38,400 Added 22.81%
206,743 $934,000
Q4 2018

Feb 14, 2019

BUY
$3.37 - $6.59 $567,315 - $1.11 Million
168,343 New
168,343 $663,000

Others Institutions Holding ANIX

About Anixa Biosciences Inc


  • Ticker ANIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,661,700
  • Market Cap $82.5M
  • Description
  • Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...
More about ANIX
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.